>So when is it time for round 2 on VRUS<
Actually, I have stopped paying attention to VRUS from an investment standpoint because, as of about 3 weeks ago, I'm working professionally on HCV-related stuff.
I'm building a list of potentially interesting biotechs. But I'm not jumping in with both feet--all I've done is take my high-yield portfolio off the DRIP, and I'm using that money (plus whatever I put in from my job) to buy biotechs again.
So far I've been building another position in RPRX, and I've bought a significant amount of BVF.